Clinical trial
Comparison of the Viveve Treatment and Cryogen-Only Treatment Versus Sham Treatment for Stress Urinary Incontinence
NCT04206085 is registered in ClinicalTrials.gov with Viveve Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the Viveve Treatment and Cryogen-Only Treatment Versus Sham Treatment for Stress Urinary Incontinence
- Lead sponsor
- Viveve Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 1, 2020
- Completion date
- August 30, 2020
- Enrollment
- 38 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
stress urinary incontinence